European Healthtech startup funding raised during November 2018.
In November 2018, 23 European Healthtech companies raised a combined €559M across 23 funding rounds, up 356.1% versus November 2017. Switzerland led by capital raised, and AXA was the most active investor. Data as of 23 Aug 2026.
1 exit.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Roivant Sciences | Other | Nov 2018 | €178M |
| Acticor biotech | Series B | Nov 2018 | €153M |
| Inflazome | Series B | Nov 2018 | €40M |
| Camel-IDS | Series A |
| Nov 2018 |
| €37M |
| AMAL | Series B | Nov 2018 | €29M |
| Fluidic Analytics | Other | Nov 2018 | €27M |
| Renalytix AI | Series A | Nov 2018 | €26M |
| Stilla Technologies | Series A | Nov 2018 | €16M |
| Nyxoah | Other | Nov 2018 | €15M |
| Mapi Pharma | Other | Nov 2018 | €8.8M |
| Birdie | Other | Nov 2018 | €7.0M |
| TeleClinic | Other | Nov 2018 | €7.0M |
| Magnisense | Other | Nov 2018 | €5.0M |
| SpinDiag | Series A | Nov 2018 | €3.0M |
| Nova Leah | Other | Nov 2018 | €2.3M |
